The 62 references in paper S. Soodaeva K., I. Klimanov A., L. Nikitina Yu., С. Соодаева К., И. Климанов А., Л. Никитина Ю. (2017) “Нитрозивный и оксидативный стресс при заболеваниях органов дыхания // Nitrosative and oxidative stresses in respiratory diseases” / spz:neicon:pulmonology:y:2017:i:2:p:262-273

1
Ricciardolo F.L.M., Caramori G., Ito K. et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease.J. Allergy Clin. Immunol.2005; 116 (5): 1028–1035. DOI: 10.1016/j.jaci.2005.06.034.
(check this in PDF content)
2
Соодаева С.К. Свободнорадикальные механизмы повреждения при болезнях органов дыхания. Пульмонология. 2012; (1): 5–10.
(check this in PDF content)
3
Sugiura H., Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide.2011; 25 (2): 138–144. DOI: 10.1016/j.niox.2011.03.079.
(check this in PDF content)
4
Dozor A.J. The role of oxidative stress in the pathogenesis and treatment of asthma. Ann. New York Academy of Sciences.2010; 1203: 133–137. DOI: 10.1111/j.17496632.2010.05562.x.
(check this in PDF content)
5
Kirkham P.A., Barnes P.J. Oxidative stress in COPD. Chest. 2013; 144 (1): 266–273. DOI: 10.1378/chest.12-2664.
(check this in PDF content)
6
Antus B., Kardos Z. Oxidative stress in COPD: molecular background and clinical monitoring.Curr. Med. Chemistry. 2015; 22 (5): 627–650.
(check this in PDF content)
7
Соодаева С.К., Климанов И.А. Нарушения окислительного метаболизма при заболеваниях респираторного тракта и современные подходы к антиоксидантной терапии. Практическая пульмонология.2009; (1): 34–38.
(check this in PDF content)
8
Соодаева С.К., Никитина Л.Ю., Климанов И.А. Механизмы развития оксидативного стресса под воздействием аэрополлютантов окружающей среды: потенциал средств антиоксидантной защиты. Пульмонология. 2015; 25 (6): 736–742. DOI: 10.18093/0869-0189-201525-6-736-742.
(check this in PDF content)
9
Berend N. Contribution of air pollution to COPD and small airway dysfunction. Respirology. 2016; 21 (2): 237–244. DOI: 10.1111/resp.12644.
(check this in PDF content)
10
BiaBas A.J., Sitarek P.B., Mibkowska-Dymanowska J. et al. The role of mitochondria and oxidative/antioxidative imbalance in pathobiology of chronic obstructive pulmonary disease. Oxid. Med. Cell. Long. 2016; 2016: 1–15. DOI: 10.1155/2016/7808576.
(check this in PDF content)
11
Владимиров Ю.А. Физико-химические основы патологии клетки: Курс лекций. М.; 2001.
(check this in PDF content)
12
Thomasi A., Ozden T., Sculachev V. Free radicals, nitric oxide, and inflammation: molecular, biochemical, and clinical aspects. In: NATO: Life and behavioural sciences. 344. Amsterdam: IOS Press; 2003: 71–88.
(check this in PDF content)
13
Соодаева С.К., Климанов И.А., Никитина Л.Ю. Особенности цикла оксида азота при респираторных заболеваниях. Пульмонология. 2016; 26 (6): 753–759. DOI: 10.18093/0869-0189-2016-26-6-753-759.
(check this in PDF content)
14
Ricciardolo F.L.M., Sterk P.J., Gaston B., Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol. Rev.2004; 84 (3): 731–765. DOI: 10.1152/physrev.00034.2003.
(check this in PDF content)
15
Ricciardolo F.L. Multiple roles of nitric oxide in the airways. Thorax. 2003; 58 (2): 175–182.
(check this in PDF content)
16
Климанов И.А., Соодаева С.К. Механизмы формирования конденсата выдыхаемого воздуха и маркеры оксидативного стресса при патологиях респираторного тракта. Пульмонология. 2009; (2): 113–119.
(check this in PDF content)
17
Hanazawa T., Kharitonov S., Barnes P.J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am. J. Respir. Crit. Care Med. 2000; 162 (4): 1273–1276. DOI: 10.1164/ajrccm.162.4.9912064.
(check this in PDF content)
18
Corradi M., Montuschi P., Donnelly L.E. et al. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care Med.2001; 163 (4): 854–858. DOI: 10.1164/ajrccm.163.4.2001108.
(check this in PDF content)
19
Malerba M., Radaeli A., Olivini A. et al. Exhaled nitric oxide as a biomarker in COPD and related comorbidities. Biomed. Res. Int.2014; 2014: 271918. DOI: 10.1155/2014/ 271918.
(check this in PDF content)
20
Formanek W., Inci D., Lauener R.P. et al. Elevated nitrite in breath condensates of children with respiratory disease. Eur. Respir. J.2002; 19 (3): 487–491.
(check this in PDF content)
21
Ho L.P., Innes J.A., Greening A.P. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax. 1998; 53 (8): 680–684.
(check this in PDF content)
22
Kharitonov S.A., Barnes P.J. Exhaled markers of inflammation.Curr. Opin. Allergy Clin. Immunol. 2001; 1 (3): 217–224.
(check this in PDF content)
23
McCafferty J.B., Bradshaw T.A., Tate S. et al. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentration. Thorax. 2004; 59: 694–698. DOI: 10.1136/thx.2003. 016949.
(check this in PDF content)
24
Климанов И.А., Соодаева С.К., Лисица А.В. и др. Стандартизация преаналитического этапа исследования конденсата выдыхаемого воздуха. Пульмонология. 2006; (2): 53–55.
(check this in PDF content)
25
Millar T., Kanczler J., Bodamyali T. et al. Nitric Oxide. Its generation, reactions and role in physiology. In: NATO Conference Proceedings. 2001; 10–11.
(check this in PDF content)
26
Latzin P., Griese M. Exhaled hydrogen peroxide, nitrite and nitric oxide in healthy children: decrease of hydrogen peroxide by atmospheric nitric oxide.Eur. J. Med. Res.2002; 7 (8): 353–358.
(check this in PDF content)
27
Emelyanov A., Fedoseev G., Abulimity A. et al. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest. 2001; 120 (4): 1136–1139.
(check this in PDF content)
28
Horvath I., Donnely L., Kiss A., Kharitonov S. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am. J. Respir. Crit. Care Med.1998; 158 (4): 1042–1046. DOI: 10.1164/ajrccm.158.4.9710091.
(check this in PDF content)
29
Ferreira I.M., Mehdi S. Hazari R.I. et al. Exhaled Nitric Oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.2001; 164 (6): 1012–1101. DOI: 10.1164/ajrccm.164.6.2012139.
(check this in PDF content)
30
Dekhuijzen P.N., Aben K.K., Dekker I. et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996; 154 (3, Pt 1): 813–816.
(check this in PDF content)
31
Beurden W.J., Dekhuijzen P.N., Harff G.A. et al. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration. 2002; 69 (3): 211–216.
(check this in PDF content)
32
Loukides S., Horvath I., Wodehouse T. et al. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am. J. Respir. Crit. Care Med.1998; 158 (3): 991–914. DOI: 10.1164/ajrccm.158.3.9710031.
(check this in PDF content)
33
Majewska E., Kasielski M., Luczynski R. et al. Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia. Respir. Med.2004; 98 (7): 669–976.
(check this in PDF content)
34
Szkudlarek U., Maria L., Kasielski M. et al. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir. Med. 2003; 97 (6): 718–725.
(check this in PDF content)
35
Antczak A., Nowak D., Bialasiewicz P. et al. Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients.Arch. Immunol. Ther. Exp.(Warsz.). 1999; 47 (2): 119–126.
(check this in PDF content)
36
Ho L.P., Faccenda J., Innes J.A. et al. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur. Respir. J. 1999; 13 (1): 103–106.
(check this in PDF content)
37
Новоселов В.И. Роль пероксиредоксинов при окислительном стрессе в органах дыхания. Пульмонология. 2012; (1): 83–87.
(check this in PDF content)
38
Варламова Е.Г., Гольтяев М.В., Новоселов С.В. и др. Характеристика некоторых представителей суперсемейства тиоловых оксидоредуктаз. Молекулярная биология.2013; 47 (4): 568–582.
(check this in PDF content)
39
Fridovich I. Superoxide radical and superoxide dismutases. Ann. Rev. Biochem.1995; 64: 97–112. DOI: 10.1146/ annurev.bi.64.070195.000525.
(check this in PDF content)
40
Tainer J.A., Getzoff E.D., Richardson J.S. et al. Structure and mechanism of copper, zinc superoxide dismutase. Nature. 1983; 306 (5940): 284–287.
(check this in PDF content)
41
Hart P.J., Balbirnie M.M., Ogihara N.L. et al. A structurebased mechanism for copper-zinc superoxide dismutase. Biochemistry. 1999; 38 (7): 2167–2178. DOI: 10.1021/ bi982284u.
(check this in PDF content)
42
Borgstahl G.E., Parge H.E., Hickey M.J. et al. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell. 1992; 71 (1): 107–118. DOI: 10.1016/00928674(92)90270-M.
(check this in PDF content)
43
Gardner P.R., Raineri I., Epstein L.B. et al. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem.1995; 270 (22): 13399–13405.
(check this in PDF content)
44
Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases.Cell. Mol. Life Sci.2004; 61 (2): 192–208. DOI: 10.1007/s00018-003-3206-5.
(check this in PDF content)
45
Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem.2000; 267 (7): 6102–6109.
(check this in PDF content)
46
Deponte M., Urig S., Arscott L.D. et al. Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase. J. Biol. Chem.2005; 280: 20628–20637. DOI: 10.1074/jbc.M412519200.
(check this in PDF content)
47
Padayatty S.J., Katz A., Wang Y. et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr.2003; 22 (1): 18–35.
(check this in PDF content)
48
Shigeoka S., Ishikawa T., Tamoi M. et al. Regulation and function of ascorbate peroxidase isoenzymes. J. Exp. Bot. 2002; 53 (372): 1305–1319.
(check this in PDF content)
49
Herrera E., Barbas C. Vitamin E: Action, metabolism and perspectives.J. Physiol. Biochem.2001; 57 (1): 43–56.
(check this in PDF content)
50
Traber M.G., Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med.2007; 43 (1): 4–15. DOI: 10.1016/j.freeradbiomed.2007.03.024.
(check this in PDF content)
51
Kelly G.S. Clinical applications of N-acetylcysteine. Altern. Med. Rev. 1998; 3 (2): 114–127.
(check this in PDF content)
52
Millea P.J. N-acetylcysteine: multiple clinical applications. Am. Fam. Physician.2009; 80 (3): 265–269.
(check this in PDF content)
53
Boesgaard S., Nielsen-Kudsk J.E., Laursen J.B. et al. Thiols and nitrates: reevaluation of the thiol depletion theory of nitrate tolerance.Am. J. Cardiol.1998; 81: 21A–29A. Соодаева С.К. Нитрозивный и оксидативный стресс при заболеваниях органов дыхания
(check this in PDF content)
54
Zafarullah M., Li W.Q., Sylvester J., Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 2003; 60 (1): 6–20.
(check this in PDF content)
55
Amini A., Masoumi-Moghaddam S., Ehteda A., Morris D.L. Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy.J. Exp. Clin. Cancer. Res. 2014; 33 (1): 92. DOI: 10.1186/s13046-014-0092-7.
(check this in PDF content)
56
Gurbuz A.K., Ozel A.M., Ozturk R. et al. Effect of N-acetyl cysteine on Helicobacter pylori.South. Med. J.2005; 98 (Suppl. 11): 1095–1097. DOI: 10.1097/01.smj.0000182486. 39913.da.
(check this in PDF content)
57
Feldman L., Efrati S., Eviatar E. et al. Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. Kidney Int.2007; 72 (3): 359–363. DOI: 10.1038/sj.ki.5002295.
(check this in PDF content)
58
Zhou J., Wang M., Sun Y. et al. Nitrate Increased Cucumber Tolerance to Fusarium Wilt by Regulating Fungal Toxin production and distribution. Toxins(Basel.). 2017; 9 (3): pii: E100. DOI: 10.3390/toxins9030100.
(check this in PDF content)
59
Tse H.N., Tseng C.Z.S. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis.2014; 9 (1): 825–836. DOI: 10.2147/COPD.S51057.
(check this in PDF content)
60
Santus P., Corsico A., Solidoro P. et al. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine. COPD. 2014; 11 (6): 705–717. DOI: 10.3109/15412555.2014.898040.
(check this in PDF content)
61
Stav D., Raz M. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. Chest. 2009; 136 (2): 381–386. DOI: 10.1378/chest.09-0421.
(check this in PDF content)
62
Stey C., Steurer J., Bachmann S. et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur. Respir. J. 2000;16 (2): 253–262. Поступила 21.03.17
(check this in PDF content)